BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 31217170)

  • 1. Association of Epstein-Barr virus serological reactivation with transitioning to systemic lupus erythematosus in at-risk individuals.
    Jog NR; Young KA; Munroe ME; Harmon MT; Guthridge JM; Kelly JA; Kamen DL; Gilkeson GS; Weisman MH; Karp DR; Gaffney PM; Harley JB; Wallace DJ; Norris JM; James JA
    Ann Rheum Dis; 2019 Sep; 78(9):1235-1241. PubMed ID: 31217170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of clinical and serological parameters of systemic lupus erythematosus patients with Epstein-Barr virus antibody profile.
    Chougule D; Nadkar M; Rajadhyaksha A; Pandit-Shende P; Surve P; Dawkar N; Khadilkar P; Patwardhan M; Kaveri S; Ghosh K; Pradhan V
    J Med Virol; 2018 Mar; 90(3):559-563. PubMed ID: 28734074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High prevalence of immunoglobulin A antibody against Epstein-Barr virus capsid antigen in adult patients with lupus with disease flare: case control studies.
    Chen CJ; Lin KH; Lin SC; Tsai WC; Yen JH; Chang SJ; Lu SN; Liu HW
    J Rheumatol; 2005 Jan; 32(1):44-7. PubMed ID: 15630723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Epstein-Barr virus antibodies in Beijing during 2013-2017: What we have found in the different patients.
    Cui J; Yan W; Xu S; Wang Q; Zhang W; Liu W; Ni A
    PLoS One; 2018; 13(3):e0193171. PubMed ID: 29494658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Investigation of Epstein-Barr virus and herpes simplex virus markers by serological and molecular methods in patients with rheumatoid arthritis and systemic lupus erythematosus].
    Us T; Cetin E; Kaşifoğlu N; Kaşifoğlu T; Akgün Y
    Mikrobiyol Bul; 2011 Oct; 45(4):677-83. PubMed ID: 22090298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus, cytomegalovirus and BK polyomavirus burden in juvenile systemic lupus erythematosus: correlation with clinical and laboratory indices of disease activity.
    Aygun D; Kuskucu MA; Sahin S; Adrovic A; Barut K; Yıldız M; Sharifova S; Midilli K; Cokugras H; Camcıoglu Y; Kasapcopur O
    Lupus; 2020 Sep; 29(10):1263-1269. PubMed ID: 32646294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serologic response to Epstein-Barr virus antigens in patients with systemic lupus erythematosus: a controlled study.
    Esen BA; Yılmaz G; Uzun S; Ozdamar M; Aksözek A; Kamalı S; Türkoğlu S; Gül A; Ocal L; Aral O; Inanç M
    Rheumatol Int; 2012 Jan; 32(1):79-83. PubMed ID: 20661740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus-specific antibodies in Epstein-Barr virus-positive and -negative gastric carcinoma cases in Japan.
    Shinkura R; Yamamoto N; Koriyama C; Shinmura Y; Eizuru Y; Tokunaga M
    J Med Virol; 2000 Apr; 60(4):411-6. PubMed ID: 10686024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serologic markers of Epstein-Barr virus reactivation are associated with increased disease activity, inflammation, and interferon pathway activation in patients with systemic lupus erythematosus.
    Wood RA; Guthridge L; Thurmond E; Guthridge CJ; Kheir JM; Bourn RL; Wagner CA; Chen H; DeJager W; Macwana SR; Kamp S; Lu R; Arriens C; Chakravarty EF; Thanou A; Merrill JT; Guthridge JM; James JA
    J Transl Autoimmun; 2021; 4():100117. PubMed ID: 35005588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to early EBV, CMV, and HHV6 antigens in systemic lupus erythematosus patients.
    Rasmussen NS; Draborg AH; Nielsen CT; Jacobsen S; Houen G
    Scand J Rheumatol; 2015; 44(2):143-9. PubMed ID: 25562120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus early antigen diffuse (EBV-EA/D)-directed immunoglobulin A antibodies in systemic lupus erythematosus patients.
    Draborg AH; Jørgensen JM; Müller H; Nielsen CT; Jacobsen S; Iversen LV; Theander E; Nielsen LP; Houen G; Duus K
    Scand J Rheumatol; 2012 Aug; 41(4):280-9. PubMed ID: 22646970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Epstein-Barr virus with systemic lupus erythematosus: effect modification by race, age, and cytotoxic T lymphocyte-associated antigen 4 genotype.
    Parks CG; Cooper GS; Hudson LL; Dooley MA; Treadwell EL; St Clair EW; Gilkeson GS; Pandey JP
    Arthritis Rheum; 2005 Apr; 52(4):1148-59. PubMed ID: 15818712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of evidence of active lytic replication of Epstein-Barr and cytomegaloviruses in patients with systemic lupus erythematosus.
    Lau CS; Yuen KY; Chan KH; Wong RW
    Chin Med J (Engl); 1998 Jul; 111(7):660-5. PubMed ID: 11245059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential role of the Epstein-Barr virus in systemic lupus erythematosus autoimmunity.
    Incaprera M; Rindi L; Bazzichi A; Garzelli C
    Clin Exp Rheumatol; 1998; 16(3):289-94. PubMed ID: 9631751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased antibody levels to stage-specific Epstein-Barr virus antigens in systemic autoimmune diseases reveal a common pathology.
    Sternbæk L; Draborg AH; Østerlund MT; Iversen LV; Troelsen L; Theander E; Nielsen CT; Jacobsen S; Houen G
    Scand J Clin Lab Invest; 2019; 79(1-2):7-16. PubMed ID: 30727744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Systemic lupus erythematosus and Epstein-Barr virus].
    Tazi I; Fehri S; Elghrari K; Ouazzani T; Benchemsi N
    East Mediterr Health J; 2009; 15(3):701-8. PubMed ID: 19731786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epstein-Barr virus infection in patients with systemic lupus erythematosus].
    Kosminsky S; de Menezes RC; Coêlho MR
    Rev Assoc Med Bras (1992); 2006; 52(5):352-5. PubMed ID: 17160312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A High Prevalence of Anti-EBNA1 Heteroantibodies in Systemic Lupus Erythematosus (SLE) Supports Anti-EBNA1 as an Origin for SLE Autoantibodies.
    Laurynenka V; Ding L; Kaufman KM; James JA; Harley JB
    Front Immunol; 2022; 13():830993. PubMed ID: 35251022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus infection as potential indicator of the occurrence and clinical presentation of systemic lupus erythematosus.
    Banko A; Cirkovic A; Miskovic R; Jeremic I; Grk M; Basaric M; Lazarevic I; Raskovic S; Despotovic A; Miljanovic D
    Front Immunol; 2023; 14():1307589. PubMed ID: 38146370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-Time PCR of cytomegalovirus and Epstein-Barr virus in adult Egyptian patients with systemic lupus erythematosus.
    Mohamed AE; Hasen AM; Mohammed GF; Elmaraghy NN
    Int J Rheum Dis; 2015 May; 18(4):452-8. PubMed ID: 24341363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.